Taltz

Indianapolis, Indiana, United States, November 11, 2026 Eli Lilly and Company has announced detailed 52-week Phase 3b clinical results...

Indianapolis, USA | March 28, 2026 Phase 3b Study Demonstrates Superior Clinical Outcomes Eli Lilly and Company has announced...